Therapeutic Outcomes in <scp>VEXAS</scp> Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Abhishek A. Mangaonkar, Ali Alsugair et al.|American Journal of Hematology|2026Cited by 1
Reduced overall survival in TP53-mutated ccus is driven by prior cytotoxic exposure and cytopenia rather than leukemic progressionSteven Tessier, Mithun Vinod Shah, Yazan Khair Eldien Jabban et al.|Blood|2025Cited by 0